Recent News

• 01.30.2026 - Immunocore announces R&D leadership evolution
• 01.09.2026 - Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference
• 11.10.2025 - Immunocore to present at upcoming investor conferences
• 11.07.2025 - Immunocore presents Phase 1 data for hepatitis B candidate at AASLD’s The Liver Meeting
• 11.06.2025 - Immunocore reports third quarter financial results and provides a business update

Recent Filings

• 01.30.2026 - 8-K Current report
• 01.09.2026 - 8-K Current report
• 01.09.2026 - EX-99.1 EX-99.1
• 12.08.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.01.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.28.2025 - 8-K Current report
• 11.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.24.2025 - 144 Report of proposed sale of securities
• 11.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 11.06.2025 - 8-K Current report